Academic Journal
Q3Cancer Diagnosis and Prognosis
About Cancer Diagnosis and Prognosis
Cancer Diagnosis and Prognosis is a scholarly journal published by International Institute of Anticancer Research. SCImago 2025 lists it in Q3, with an SJR of 0.438 and H-index of 14.
Coverage: 2021-2026. Research categories: Oncology (Q3); Cancer Research (Q4).
Source-backed journal facts
Topics in published research
Inflammatory Biomarkers in Disease Prognosis; Cancer Immunotherapy and Biomarkers; Nutrition and Health in Aging; Colorectal Cancer Surgical Treatments; Renal cell carcinoma treatment; Prostate Cancer Treatment and Research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Malignant Myoepithelioma Arising from the Upper Arm With Brachial Plexus Involvement: A Rare Case
HAYATO TATSUMI, TOSHIHIRO MATSUO, TAKASHI NISHISAKA, YUI HATTORI et al.
2026-09-01 · DOI: 10.21873/cdp.10596Co-expression of the Mammaglobin (SCGB2A2) Gene With hsa-miR-184 and hsa-miR-190b Indicates Its Possible Role in Oncogenic Pathways in Breast Cancer
JUAN FELIPE ABELLA-DUQUE, LILIANA LÓPEZ-KLEINE, RAFAEL PARRA-MEDINA, SANDRA RAMÍREZ-CLAVIJO et al.
2026-09-01 · DOI: 10.21873/cdp.10586Preoperative Magnetic Resonance Imaging Findings of the Transition Zone Predict Incidental Prostate Cancer in HoLEP
TOSHIKI ITO, YUSAKU HISAMATSU, SHUHEI MIZUTANI, TAKASHI KODAMA et al.
2026-09-01 · DOI: 10.21873/cdp.10591Jejunal Mixed Adenoneuroendocrine Carcinoma (MANEC) With a Novel PTPRK-RSPO3 Fusion Initially Presenting as a Large Ovarian Mass: Diagnostic Challenges and Poor Prognosis
RAN WANG, JINPING LAI
2026-09-01 · DOI: 10.21873/cdp.10594Immune Checkpoint Inhibitor Resistance in Rectal Adenocarcinoma Containing a Mismatch Repair Deficiency Component: A Case Report
KOHEI OKURA, HARUKA TAKENAKA, HIROSHI FUJITA, NORIHISA HANADA et al.
2026-09-01 · DOI: 10.21873/cdp.10595Real-world Outcomes of First-line Platinum-based Chemotherapy in Patients Aged 80 Years or Older With Metastatic Urothelial Carcinoma
AKINORI MINATO, KAZUMASA JOJIMA, YUTO TSUBONUMA, YUI MIZUSHIMA et al.
2026-09-01 · DOI: 10.21873/cdp.10589Transcriptomic Association Between Poliovirus Receptor (PVR/CD155) and Claudin Signaling Pathways in Colorectal Cancer
STEVEN LEHRER, PETER H. RHEINSTEIN
2026-09-01 · DOI: 10.21873/cdp.10585Casein Kinase 1 Alpha 1 Is Over-expressed in Pancreatic Adenocarcinoma Tissues and Correlates With Shorter Patient Survival
SHIN-NOSUKE YAMASHITA, YOSHIATSU TANAKA, SHAJEDUL ISLAM, TAKAO KITAGAWA et al.
2026-09-01 · DOI: 10.21873/cdp.10584Prognostic Impact of Recurrence Location in Locally Recurrent Rectal Cancer: A Single-Center Retrospective Study
SHO NAMBARA, KOJI ANDO, TETSURO KAWAZOE, SHOTARO KOREHISA et al.
2026-09-01 · DOI: 10.21873/cdp.10588Prognostic Significance of Number of Liver Metastases in Patients With Advanced Pancreatic Cancer Receiving Nab-paclitaxel Plus Gemcitabine
KIYOTSUGU IEDE, TERUMASA YAMADA, HIROTOSHI TAKAYAMA, MASARU SASAKI et al.
2026-09-01 · DOI: 10.21873/cdp.10592Two Cases of Uterine Small-cell Neuroendocrine Carcinoma With Somatostatin-receptor-type-2 (SSTR2) Expression and Minor Components of Endocervical Adenocarcinoma
MASAMICHI BAMBA, TOMO NAMURA, TOSHIKAZU KATO, MASANORI SHIOHARA et al.
2026-09-01 · DOI: 10.21873/cdp.10593First-line Enfortumab Vedotin Plus Pembrolizumab in Platinum-ineligible Advanced Urothelial Carcinoma
GO KANEKO, DAISUKE IGARASHI, SUGURU SHIROTAKE
2026-09-01 · DOI: 10.21873/cdp.10590Reduced HMGCR Expression in Clear Cell Renal Cell Carcinoma Is Associated With Poor Patient Prognosis
ETSUSHI AKITAYA, YUZUKI NAKAMURA, SHIHO KATO, HINAYO KIKUTA et al.
2026-09-01 · DOI: 10.21873/cdp.10587Impact of Local Treatment of the Primary Tumor on Overall Survival in De Novo Metastatic Breast Cancer: A Systematic Review and Meta-analysis
LUISANA SISCA, MARIAM GRAZIA POLITO, MICHELE IULIANI, GIUSEPPE TONINI et al.
2026-07-01 · DOI: 10.21873/cdp.10562Possible Sarcopenia and Functional Decline After Colorectal or Gastric Cancer Surgery
NAOHIRO FURUYA, JUNICHI ANDO, HINATA MURAKAMI, AOI HASHIMOTO et al.
2026-07-01 · DOI: 10.21873/cdp.10575Total Bone Uptake as a Quantitative Imaging Biomarker for Prostate Cancer With Bone Metastases
SHUNSUKE WATANABE, DAISUKE MOTOYAMA, KYOHEI WATANABE, HIROMITSU WATANABE et al.
2026-07-01 · DOI: 10.21873/cdp.10576From Ascites to Malignant Peritoneal Mesothelioma: The Diagnostic Workup of a Rare Tumor
MIRKO NASTASI, CHIARA FERRANTE, GIULIANA MICHELIS, ENRICA BRANCA et al.
2026-07-01 · DOI: 10.21873/cdp.10581HER2 Expression and Nuclear Localization in Clear Cell Renal Cell Carcinoma: Implications for Prognosis and Therapeutic Targeting
MARÍA ALICIA CORTÉS, HÉCTOR MARCELO MARÍN, NADIA BARBÁS, ROSALIA CORDO-RUSO et al.
2026-07-01 · DOI: 10.21873/cdp.10565Living-donor Kidney Transplantation After Resection of Mixed Epithelial and Stromal Tumor: A Positive Outcome Despite Not Observing the Recommended Waiting Period
KEISUKE NAKAI, YUKI KOBARI, MAYU HAKOZAKI, TAKASHI IKEDA et al.
2026-07-01 · DOI: 10.21873/cdp.10567When Blood Speaks Before the Scan: The Role of ctDNA in Real-time CRC Care
NASIM SALIMIAGHDAM, EMMA LI, HONGYAN LIANG
2026-07-01 · DOI: 10.21873/cdp.10578Reviews
Community Reviews
Version History
October 4, 2026 at 9:22 pm
October 2, 2026